Irazu Oncology

Developer of a vaccine platform designed to improve clinical outcomes for cancer patients. The company develops novel, effective, and cost-effective cancer vaccines that initially target colorectal ca...

Healthcare

Baltimore, MD, United States

Founded 2022

9 employees

Website

Valuation

Share Price

N/A

Total Raised

$2.6M

Last Round

N/A

Investors

+6 other investors

View all 6 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock Irazu Oncology's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required